Please login to the form below

Not currently logged in
Can medical technology afford market access?

Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

Despite companies striving to improve patient care, many still struggle to gain market access - governed by three main factors: evidence requirements, the reimbursement landscape and defining clinical and economic value for medical devices.

On 18 November Adelphi Values and two expert speakers, in association with PME, will explain these multiple challenges and discuss key considerations, potential challenges and solutions for gaining successful market access for often life-changing medical technologies.

I would like to invite you to register for this webinar - either to watch it live on the day or for access to a recorded version.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...